The Living Well After Cancer™ Program
The University of Pennsylvania's Program for Cancer Survivors
The Abramson Cancer Center of the University of Pennsylvania is committed to helping each cancer survivor find ways to enjoy life to the fullest. We have a nationally recognized program that focuses on the issues that survivors face, called "Living Well After Cancer™."
The LIVESTRONG™ Survivorship Center of Excellence, The Living Well After Cancer Program (LWAC) at the Abramson Cancer Center, directed by Linda A. Jacobs, PhD, RN, is a clinical, research, and education effort focused on early intervention and prevention of disease as the ultimate goal. The multidisciplinary LWAC Program currently provides care and research opportunities to cancer survivors treated at Penn, the Penn Cancer Network hospitals, and through the Living Well After Childhood Cancer™ Program, a collaborative effort between Penn and CHOP.
The LWAC Program was initially funded by a seed grant from the Lance Armstrong Foundation in 2001. In 2007 the ACC was awarded designation as a Survivorship Center of Excellence and invited to join the LIVESTRONG™ Survivorship Center of Excellence Network, a group of eight comprehensive Cancer Centers that have been chosen over the last few years to lead the effort across the country in clinical care and research with cancer survivors of all ages.
Thanks to the funding and collaborative opportunities provided by LWAC Program's designation as a LIVESTRONG™Survivorship Center of Excellence, the Penn Program has begun three exciting initiatives:
We work with your primary oncologist or primary care doctor and focus on medical, personal, social, and economic concerns as well as strategies for maintaining long-term health and well-being.
You will complete a questionnaire and tell us about any symptoms you are experiencing that can help to identify some of the potential late effects of your cancer treatment.
These questions will help to identify:
To learn about what sets us apart, visit:
Nicholas Martell was first diagnosed with prostate cancer more than ten years ago. He was healthy for many years after being treated with radiation therapy. Nick recently experienced a recurrence of his cancer. Physicians at Penn tailored his treatment and enrolled him in a new Phase I clinical trial using laser-based photodynamic therapy (PDT) followed by hormone therapy. This leading edge treatment plan was effective. Nick just returned from a vacation with his daughter, and in his free time, he plays golf every chance he gets.